Sign In
Buy DHR
$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
This Stock Is Up Over 52,700% Since Founding. Should Investors Buy After Its 36% Decline?
02:15pm, Friday, 24'th Apr 2026
This blue chip stock has been in a multiyear slump, but things are looking up.
Arizona State Retirement System Sells 6,790 Shares of Danaher Corporation $DHR
03:48am, Friday, 24'th Apr 2026
Arizona State Retirement System decreased its position in shares of Danaher Corporation (NYSE: DHR) by 3.6% during the undefined quarter, according to its most recent filing with the Securities and Ex
Danaher reaches $172.5 million settlement with shareholders over post-pandemic outlook
01:39pm, Thursday, 23'rd Apr 2026
Danaher reached a $172.5 million settlement with shareholders who accused the diagnostics and life-sciences company of defrauding them by overstating demand for its equipment as the worst of the
Danaher Announces Pricing of Euro-Denominated Senior Notes Offering
07:15pm, Wednesday, 22'nd Apr 2026
WASHINGTON, April 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced an offering of the following euro-denominated senior notes (the "Offering"): �
Danaher Q1 2026 Earnings Update
02:30pm, Wednesday, 22'nd Apr 2026
Danaher had another somewhat uneventful quarter. Margin in biotechnology segment improved YoY to reach 42.7% in 1Q'26. Life Sciences segment's core revenue grew at only 0.5% despite having an easy com
Danaher Q1 Earnings Call Highlights
04:58am, Wednesday, 22'nd Apr 2026
Danaher (NYSE: DHR) reported first-quarter 2026 sales of $6.0 billion, with core revenue up 0.5% year over year as strength in bioprocessing and better-than-expected life sciences performance largely
Danaher Q1 Earnings Beat Estimates, Life Sciences Sales Up Y/Y
01:31pm, Tuesday, 21'st Apr 2026
DHR beats Q1 EPS estimates and lifts 2026 outlook, but revenues miss as Diagnostics lags while bioprocessing strength and Masimo deal shape growth plans.
LH or DHR: Which Is the Better Value Stock Right Now?
12:42pm, Tuesday, 21'st Apr 2026
Investors interested in Medical Services stocks are likely familiar with Labcorp Holdings (LH) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
Danaher Q1 Earnings Beat Estimates, But Revenue Miss, Weak Diagnostics Weigh On Stock
12:00pm, Tuesday, 21'st Apr 2026
Danaher Corp (NYSE:DHR) on Tuesday reported first-quarter 2026 sales of $5.95 billion, up 3.5% year-over-year, but under the consensus of $5.99 billion. Core revenue increased 0.5% year-over-year.
Danaher Corporation (DHR) Q1 2026 Earnings Call Transcript
11:20am, Tuesday, 21'st Apr 2026
Danaher Corporation (DHR) Q1 2026 Earnings Call Transcript
Danaher (DHR) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
10:31am, Tuesday, 21'st Apr 2026
Although the revenue and EPS for Danaher (DHR) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street e
Danaher Corp. May Be the Smartest Bet in Biotech Right Now
08:46am, Tuesday, 21'st Apr 2026
If biotech funding continues to increase this year, Danaher could benefit.
Danaher (DHR) Q1 Earnings Beat Estimates
08:15am, Tuesday, 21'st Apr 2026
Danaher (DHR) came out with quarterly earnings of $2.06 per share, beating the Zacks Consensus Estimate of $1.95 per share. This compares to earnings of $1.88 per share a year ago.
Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains
07:33am, Tuesday, 21'st Apr 2026
Danaher boosted the upper end of its full-year earnings guidance, following a first-quarter beat fueled by double-digit momentum in its Biotechnology and Life Sciences segments.
Danaher beats first-quarter profit estimates on strong bioprocessing demand
07:28am, Tuesday, 21'st Apr 2026
Life sciences firm Danaher topped first-quarter profit expectations on Tuesday, fueled by strong demand for its bioprocessing tools used in drug manufacturing, lifting shares 2% in premarket tradin
